WiLAN Subsidiary Acquires Medical Patent Portfolio
June 10 2014 - 9:40AM
Marketwired
WiLAN Subsidiary Acquires Medical Patent Portfolio
OTTAWA, CANADA--(Marketwired - Jun 10, 2014) - Wi-LAN Inc.
("WiLAN" or the "Company") (TSX:WIN)(NASDAQ:WILN) today announced
that a subsidiary has acquired a portfolio of medical patents that
relate to Stent technology.
"With the acquisition of this medical technology, and a strong
opportunity pipeline, WiLAN is seeing significant demand from
inventors and small companies, in diverse markets, looking to
monetize their valuable inventions," said Jim Skippen, President
& CEO. "The acquired technology helps address vascular blood
flow complications."
The acquisition of this portfolio will be funded through an
upfront payment and the sharing of net revenues generated by
licensing the patents. WiLAN can confirm that it does not consider
the upfront payment amount to be material relative to its current
cash position. All other terms of the agreement are
confidential.
About WiLAN
WiLAN, founded in 1992, is a leading technology innovation and
licensing company. WiLAN has licensed its intellectual property to
over 280 companies worldwide. Inventions in our portfolio have been
licensed by companies that manufacture or sell a wide range of
communication and consumer electronics products including 3G and 4G
handsets, Wi-Fi-enabled laptops, Wi-Fi and broadband routers, xDSL
infrastructure equipment, cellular base stations and digital TV
receivers. For more information: www.wilan.com.
Forward-looking Information
This news release contains forward-looking statements and
forward-looking information within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and other United States
and Canadian securities laws. The phrases "will be", "generated by"
and similar terms and phrases are intended to identify these
forward-looking statements. Forward-looking statements and
forward-looking information are based on estimates and assumptions
made by WiLAN in light of its experience and its perception of
historical trends, current conditions, expected future developments
and the expected effects of new business strategies and expected
future developments, as well as other factors that WiLAN believes
are appropriate in the circumstances. Many factors could cause
WiLAN's actual performance or achievements to differ materially
from those expressed or implied by the forward-looking statements
or forward-looking information. Such factors include, without
limitation, the risks described in WiLAN's February 3, 2014 annual
information form for the year ended December 31, 2013 (the "AIF").
Copies of the AIF may be obtained at www.sedar.com or www.sec.gov.
WiLAN recommends that readers review and consider all of these risk
factors and notes that readers should not place undue reliance on
any of WiLAN's forward-looking statements. WiLAN has no intention
and undertakes no obligation to update or revise any
forward-looking statements or forward-looking information, whether
as a result of new information, future events or otherwise, except
as required by law.
All trademarks and brands mentioned in this release are the
property of their respective owners.
For media and investor inquiries,Tyler BurnsDirector, Investor
RelationsO: 613.688.4330C: 613.697.0367E: tburns@wilan.com
Quarterhill (NASDAQ:QTRH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quarterhill (NASDAQ:QTRH)
Historical Stock Chart
From Apr 2023 to Apr 2024